ONWRF
Price
$4.60
Change
-$0.39 (-7.82%)
Updated
Jul 23 closing price
Capitalization
220.76M
VIGL
Price
$8.05
Change
-$0.00 (-0.00%)
Updated
Jul 25 closing price
Capitalization
375.71M
17 days until earnings call
Interact to see
Advertisement

ONWRF vs VIGL

Header iconONWRF vs VIGL Comparison
Open Charts ONWRF vs VIGLBanner chart's image
Onward Med
Price$4.60
Change-$0.39 (-7.82%)
Volume$3.93K
Capitalization220.76M
Vigil Neuroscience
Price$8.05
Change-$0.00 (-0.00%)
Volume$465.97K
Capitalization375.71M
ONWRF vs VIGL Comparison Chart in %
Loading...
ONWRF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VIGL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ONWRF vs. VIGL commentary
Jul 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ONWRF is a Hold and VIGL is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 26, 2025
Stock price -- (ONWRF: $4.60 vs. VIGL: $8.05)
Brand notoriety: ONWRF and VIGL are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ONWRF: 434% vs. VIGL: 29%
Market capitalization -- ONWRF: $220.76M vs. VIGL: $375.71M
ONWRF [@Biotechnology] is valued at $220.76M. VIGL’s [@Biotechnology] market capitalization is $375.71M. The market cap for tickers in the [@Biotechnology] industry ranges from $313.33B to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ONWRF’s FA Score shows that 0 FA rating(s) are green whileVIGL’s FA Score has 0 green FA rating(s).

  • ONWRF’s FA Score: 0 green, 5 red.
  • VIGL’s FA Score: 0 green, 5 red.
According to our system of comparison, VIGL is a better buy in the long-term than ONWRF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ONWRF’s TA Score shows that 5 TA indicator(s) are bullish while VIGL’s TA Score has 3 bullish TA indicator(s).

  • ONWRF’s TA Score: 5 bullish, 4 bearish.
  • VIGL’s TA Score: 3 bullish, 2 bearish.
According to our system of comparison, VIGL is a better buy in the short-term than ONWRF.

Price Growth

ONWRF (@Biotechnology) experienced а -6.12% price change this week, while VIGL (@Biotechnology) price change was -0.25% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.58%. For the same industry, the average monthly price growth was +17.35%, and the average quarterly price growth was +27.29%.

Reported Earning Dates

VIGL is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Biotechnology (+7.58% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VIGL($376M) has a higher market cap than ONWRF($221M). VIGL YTD gains are higher at: 373.529 vs. ONWRF (-23.333).
ONWRFVIGLONWRF / VIGL
Capitalization221M376M59%
EBITDAN/A-91.27M-
Gain YTD-23.333373.529-6%
P/E RatioN/AN/A-
RevenueN/A0-
Total CashN/A87.1M-
Total DebtN/A12.7M-
TECHNICAL ANALYSIS
Technical Analysis
ONWRFVIGL
RSI
ODDS (%)
Bullish Trend 1 day ago
33%
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
45%
Bearish Trend 1 day ago
89%
Momentum
ODDS (%)
Bearish Trend 1 day ago
50%
Bullish Trend 5 days ago
90%
MACD
ODDS (%)
Bearish Trend 1 day ago
54%
N/A
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
46%
Bearish Trend 1 day ago
85%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
37%
Bullish Trend 1 day ago
84%
Advances
ODDS (%)
Bullish Trend 5 days ago
50%
Bullish Trend 13 days ago
87%
Declines
ODDS (%)
N/A
N/A
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
20%
Bearish Trend 1 day ago
77%
Aroon
ODDS (%)
Bearish Trend 5 days ago
53%
Bullish Trend 1 day ago
80%
View a ticker or compare two or three
Interact to see
Advertisement
ONWRF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VIGL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TECHX21.370.04
+0.19%
WisdomTree Technology and Inn 100 DgtN/A
THOGX44.850.07
+0.16%
Thornburg Global Opportunities R6
BSGIX16.08N/A
N/A
Baird Small/Mid Cap Growth Institutional
FSRTX8.68N/A
N/A
Fidelity Advisor Strategic Real Ret M
VVOIX22.56N/A
N/A
Invesco Value Opportunities Y

ONWRF and

Correlation & Price change

A.I.dvisor indicates that over the last year, ONWRF has been loosely correlated with SHJBF. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if ONWRF jumps, then SHJBF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ONWRF
1D Price
Change %
ONWRF100%
N/A
SHJBF - ONWRF
42%
Loosely correlated
N/A
CNTA - ONWRF
24%
Poorly correlated
-0.45%
UCBJF - ONWRF
23%
Poorly correlated
+1.62%
INO - ONWRF
22%
Poorly correlated
-2.65%
VIGL - ONWRF
9%
Poorly correlated
N/A
More

VIGL and

Correlation & Price change

A.I.dvisor indicates that over the last year, VIGL has been loosely correlated with MRUS. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if VIGL jumps, then MRUS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VIGL
1D Price
Change %
VIGL100%
N/A
MRUS - VIGL
49%
Loosely correlated
+1.72%
IMNN - VIGL
47%
Loosely correlated
-7.24%
OABI - VIGL
37%
Loosely correlated
-0.94%
ELVN - VIGL
36%
Loosely correlated
-3.42%
RCKT - VIGL
36%
Loosely correlated
-2.18%
More